Study the effect of Haritakyadi Eye drops in immature senile cataract

Ã¢â?¬Å?Randomized controlled clinical study to assess the effect of Haritakyadi Eye drops in immature senile cataract.Ã¢â?¬?

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/07/034523

Enrollment

100

Registered

2021-07-02

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: H250- Age-related incipient cataract

Interventions

Intervention1: HARITAKYADI EYE DROPS: HARITAKYADI EYE DROPS CONTAINS HARITAKI, HARIDRA,PIPPALI AND SAINDHAV, 2 drops 2 times per day, duration for 30 days Intervention2: HARITAKYADI EYE DROPS: HARITAK

Eligibility

Inclusion criteria

Inclusion criteria: Patients having sign and symptoms of immature senile cataract. Patient having vision 6/60 or more

Exclusion criteria

Exclusion criteria: Patient other than immature senile cataract. Patient having vision less than 6/60. Patient having any fundus pathology. Patients with hypertension, diabetes, other cardiac problems

Design outcomes

Primary

Measure	Time frame
To evaluate the effect of Haritakyadi Eye drops in sign and symptoms of immature senile cataractTimepoint: assessment done at 7 days, 15 days, 30 days	—

Secondary

Measure	Time frame
To study the patalagat doshdushti (Timira) To study in detail immature senile cataract. To study beneficial effect of Ancient mode of treatment in modern era. To study the physiochemical parameters of Haritakyadi eye drops. To study the adverse effect of Haritakyadi Eye drops if any. Timepoint: 7th, 15th and 30 th days for trial medication observation and 60 th day for observation only. Total study duration is of 2 years.	—

Measure

Time frame

To study the patalagat doshdushti (Timira) To study in detail immature senile cataract. To study beneficial effect of Ancient mode of treatment in modern era. To study the physiochemical parameters of Haritakyadi eye drops. To study the adverse effect of Haritakyadi Eye drops if any. Timepoint: 7th, 15th and 30 th days for trial medication observation and 60 th day for observation only. Total study duration is of 2 years.

—

Countries

India

Contacts

Public Contactpragati gajabhe

YASHWANT AYURVED MAHAVIDYALAYA

drcnm05@gmail.com9175800710

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026